June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Paradoxical Role of Caveolin-1 in Retinal Inflammation
Author Affiliations & Notes
  • Michael Elliott
    Ophthalmology, OUHSC, Oklahoma City, OK
  • Xiaoman Li
    Key Laboratory of Medical Cell Biology, China Medical University, Shengyan, China
  • Xiaowu Gu
    Ophthalmology, OUHSC, Oklahoma City, OK
  • Alaina Reagan
    Ophthalmology, OUHSC, Oklahoma City, OK
  • Timothy Boyce
    Ophthalmology, OUHSC, Oklahoma City, OK
  • Ilya Sluch
    Ophthalmology, OUHSC, Oklahoma City, OK
  • Md Nawajes Mandal
    Ophthalmology, OUHSC, Oklahoma City, OK
  • Michelle Callegan
    Ophthalmology, OUHSC, Oklahoma City, OK
  • Daniel Carr
    Ophthalmology, OUHSC, Oklahoma City, OK
  • Footnotes
    Commercial Relationships Michael Elliott, None; Xiaoman Li, None; Xiaowu Gu, None; Alaina Reagan, None; Timothy Boyce, None; Ilya Sluch, None; Md Nawajes Mandal, None; Michelle Callegan, None; Daniel Carr, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3180. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael Elliott, Xiaoman Li, Xiaowu Gu, Alaina Reagan, Timothy Boyce, Ilya Sluch, Md Nawajes Mandal, Michelle Callegan, Daniel Carr; Paradoxical Role of Caveolin-1 in Retinal Inflammation. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3180.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Recent evidence indicates that caveolin-1 (Cav-1), the signature protein of caveolae membrane microdomains, modulates inflammatory responses and innate immunity. In the uveitic retina, Cav-1 expression is dramatically upregulated, particularly in Müller glial cells (Hauck et al., 2010, Mol Cell Proteomics). However, Cav-1’s role in retinal inflammation has not been rigorously tested. In the current study, we examined the effect of Cav-1 ablation on the sensitivity of the retina to inflammation.

Methods: Cav-1 knockout (KO) mice were challenged by intravitreal injection of the Toll-like receptor-4 (TLR4) agonist, lipopolysaccharide (LPS), and inflammation was assessed by flow cytometry, immunohistochemistry, and spectral domain optical coherence tomography. Levels of chemoattractants were determined by multiplex immunoassays. Leukostasis was assessed in retinal flatmounts after perfusion with FITC-labeled Concanavalin A (FITC-ConA). Microarray analysis was performed on Cav-1 KO and control retinas/eyecups and the dataset was analyzed by Gene Set Enrichment Analysis (KEGG pathways, gene ontologies, and Ingenuity Pathway Analysis).

Results: Analysis of microarray data (n = 6) revealed a remarkable upregulation of mRNAs associated with inflammatory processes and innate immune responses. Intravitreal challenge with LPS induced a significant increase in the number of infiltrating bone marrow-derived (CD45hi) cells in Cav-1 KO retinas compared to controls as measured by flow cytometry. Increased leukostasis was visualized by FITC-ConA labeling of retinal flatmounts. Given the role of Cav-1 modulation of TLR signaling, we predicted that Cav-1 ablation would result in enhanced TLR4 signaling. Paradoxically, the protein levels of chemoattractant effectors downstream of TLR4 (monocyte chemotactic protein-1/CCL2, CXCL1/KC, interleukin-6, and interleukin-1b) were all significantly reduced in retinal extracts from Cav-1 KO compared to control mice.

Conclusions: This paradox suggests that Cav-1 modulates inflammatory signaling and leukocyte infiltration through distinct mechanisms. We hypothesize that Cav-1 expression may enhance inflammatory signaling while at the same time supporting the physical properties of the blood-retinal barrier.

Keywords: 557 inflammation • 688 retina • 448 cell membrane/membrane specializations  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×